RepORt Biomatter 12 174181 OctoberNovemberDecember 2011 2011 Landes Bioscience Development affinitybased delivery NGF chondroitin sulfate biomaterial Karen Chao Butterfield1 Aaron W Conovaloff2 Alyssa panitch2 1Harrington Department Bioengineering Arizona State University tempe AZ 2Weldon School Biomedical engineering purdue University West Lafayette IN USA Key words chondroitin sulfate nerve growth factor spinal cord injury hydrogel nerve regeneration controlled release Abbreviations ANOVA analysis variance BP binding peptide BSA bovine serum albumin C6S chondroitin6sulfate CS chondroitin sulfate CSPG chondroitin sulfate proteoglycan DRG dorsal root ganglion EDTA ethylenediaminetetraacetic acid GAG glycosaminoglycan NGF nerve growth factor PEG polyethylene glycol Mal maleimide PBS phosphate buffered saline SE standard error Chondroitin sulfate major component extracellular matrix central peripheral nervous systems Chondroitin sulfate upregulated injury methods promote neurite extension chondroitin sulfaterich matrices synthetic scaffolds needed We use chondroitin sulfate novel chondroitin sulfatebinding peptide control release nerve growth factor Interestingly novel chondroitin sulfatebinding peptide enhances controlled release properties chondroitin sulfate gels While introduction chondroitin sulfate scaffold inhibits primary cortical outgrowth combination chondroitin sulfate chondroitin sulfate binding peptide nerve growth factor promotes primary cortical neurite outgrowth chondroitin sulfate gels Introduction Chondroitin sulfate CS glycosaminoglycan GAG attached protein core form proteoglycan Chondroitin sulfate proteoglycans CSPGs play important role extracellular matrix central nervous system1 In neuronal development regeneration CSPGs modulate wide range activities cell adhesion division synaptic plastic ity regeneration23 studies shown activity CSPGs attributed sulfation pattern CS chains46 Previous work investigated effects CS GAG vitro solution adsorbed flat surface710 examined effects neurite outgrowth dimensional gels61112 CSbased biomaterials developed variety applications including cartilage tissue engineering1314 wound healing15 In studies CS modified covalent crosslinking gel synthesis incorporation scaffold chemical modification CS interfere potential binding sites reduce CS bioactivity Other systems physically entrap CS matrix dif fusion CS controlled physical properties bio material16 Other GAGs incorporated hydrogels cases added integrating GAGbinding domains biomaterial SakiyamaElbert et al developed affinitybased heparin incorporated fibrin matrices heparinbinding peptides1718 This group shown growth factor activ ity regulated GAGbinding sequestration localization growth factor activity19 SakiyamaElbert et al improved neurite outgrowth vitro2022 vivo23 affinitybased delivery neurotrophins Our lab developed polyethylene glycolPEGco peptide polysaccharide tunable viscoelastic biological properties seen Figure 12427 In earlier studies incorporated heparin order bind cellpene trating peptides In current study modified mate rial specifically incorporate CS advantage native interactions CS nerve growth factor NGF controlled release The mechanical properties material controlled physical interactions GAGbinding peptides covalently bound eightarm PEG GAGs crosslinking eightarm PEG black lines bifunctional enzymatically degradable crosslinking peptides dark gray dumbbells include integrinbinding sequence RGD Unmodified CS striped stars entrapped biomaterial interactions CSbinding peptides light gray hexagons conjugated eightarm PEG Finally CS provides binding sites incorporation NGF spotted triangles In earlier work demonstrated viability chondroitin 6sulfate C6Sbased scaffolds support outgrowth dorsal root ganglia DRGs vitro28 Thus potential use therapeutic implantable hydrogel promote regen eration neurons traumatic root avulsion brachial plexus Correspondence Alyssa Panitch Email apanitchpurdueedu Submitted 072111 Revised 092911 Accepted 111611 httpdxdoiorg104161biom1218791 174 Biomatter Volume 1 Issue 2 2011 Landes BioscienceDo distribute RepORt RepORt RepORt Table 1 Gel compositions Gel Rheology peG peGC6S peGBp peGBpC6S NGF Release peGNGF peGC6SNGF peGBpNGF peGBpC6SNGF Cotical Cell Culture peGBp peGBpC6S peGBpNGF peGBpC6SNGF C6Sbinding C6S NGF addition C6S BP significantly affected viscoelastic properties gels From frequency sweep 10 rads chosen lin ear viscoelastic range time sweep performed 05 strain 6 min Figure 3 shows averaged complex modulus different gel compositions At 10 rads 05 strain PEG gel 100 Pa significantly p 005 stronger gels C6S andor BP The weakest gel 38 Pa tained BP C6S PEGBPC6S statistically different p 005 gels contained C6S PEG C6S BP PEGBP These results demonstrate PEG gels contain BP C6S significantly weaker gels BP C6S To demonstrate inclusion C6S provide trolled release mechanism studies investigate NGF release gel compositions shown Table 1 The NGF released 48 h quantified ELISA kit As negative controls NGF release gels C6S BP monitored determine C6S BP affected NGF release PEG gels The release profiles gels shown Figure 4 PEG gels contained C6S PEGC6S fastest NGF release gels contained BP C6S slowest release profile PEGBPC6S The twoway ANOVA analysis showed addition BP PEG gels signifi factor affecting NGF release C6S Table 2 shows results posthoc test determine significance NGF release gels different time points 048 h At earlier time points 07 h NGF released PEGC6S gel significantly greater NGF released gels BP Table 2 light shading At later time points 448 h NGF release significantly slower PEGBPC6S gels Table 2 dark shading These results PEG gels contain BP slower NGF release profile compared PEG controls gels contain BP C6S demonstrate slowest NGF release profile Figure 1 Affinitybased NGF delivery peGcopeptide CS eightarm peG black lines modified bifunctional crosslinking peptides dark gray dumbbells 6 arms CSbinding peptides light gray hexagons 2 arms CS striped stars interacts CS binding peptides NGF spotted triangles injuries However regeneration injuries require peripheral central nerve growth previous studies revealed C6S inhibits regeneration central neu rons29 This lack central nervous neuronal growth likely prevent successful reintegration central periph eral nervous systems C6Sbased material implanted vivo model Incorporation C6Sbinding peptide described previous work investigated current work help block inhibitory signals promote recovery traumatic root avulsion brachial plexus injuries2930 To validate vitro potential use therapy investigated controlled release NGF C6Sbased biomaterial In addition investigated effects NGF release primary cortical neurite outgrowth Controlled release NGF achieved noncovalent interac tions NGF CS CSbinding peptide Neurite growth inhibited gels included C6S inhibition overcome NGF incorporated gel Results To investigate effect peptide CS incorporation PEG gels viscoelastic properties gels compositions shown Table 1 investigated rheology As negative controls gels C6S andor BP binding peptide tested Figure 2 shows complex modulus G differ ent gel compositions 0550 rads frequency 05 strain The PEG gel C6S BP PEG strongest PEG gel C6S BP PEGBPC6S weakest The twoway repeated measures ANOVA showed wwwlandesbiosciencecom Biomatter 175 2011 Landes BioscienceDo distribute To examine effects C6S BP controlled NGF release gels neurite outgrowth cortical neu rons cultured PEG gels differ ent compositions Table 1 48 h The average maximum length num ber neurites quantified neuron Approximately 80200 neurons analyzed gel composition Figure 5 shows 1 average neurite length 2 maximum neurite length 3 number neurites gel composition Controls consisted neu rons cultured PEG gels include C6S andor NGF PEG gels included C6S PEGC6S lower averagemaximum neurite length number neurites compared PEG gels C6S PEGBP Therefore C6S inhibits neurite outgrowth PEG gels When NGF incorporated PEG gels PEGBPNGF average maximum neurite lengths sig nificantly higher gels NGF PEGBP PEGBPC6S In gels C6S neurite length NGF PEGBPC6SNGF significantly higher gels NGF PEGBP PEGBPC6S These results Fig 5A B NGF incorporation PEG gels stimulates neurite growth overcomes inhibitory effects C6S Neurons cultured PEGBPNGF number neurites neu rons cultured PEGBP Furthermore neurons cultured PEGBPC6SNGF number neurites neu rons cultured PEGC6S Fig 5C Therefore NGF effect number neurites The results cor tical neuron culture PEG gels Fig 5 showed C6S decreased neurite growth NGF increased neurite length Discussion Figure 2 Frequency sweep 05500 rads gels 05 strain peG gels C6S Bp highest viscoelastic properties gels C6S andor Bp significantly lower complex moduli Mean Se Figure 3 time sweep peG gels 10 rads 05 strain peG gels contained C6S Bp significantly lower complex moduli gels C6S Bp Mean Se p 005 different relative peG The PEGcopeptide polysaccharide biomaterial developed Seal Panitch2426 model investigate effects affinitybased delivery biological molecules cortical neuron behavior In study modified PEGcopeptide poly saccharide incorporating C6S C6Sbinding peptides conjugated eightarm PEG heparin heparinbinding peptides original materials Rheological results shown Figure 1 demonstrate PEG gels included C6Sbinding peptide andor C6S weaker PEG gels C6S C6Sbinding peptide The crosslink ing reaction bifunctional peptides PEGmaleimide Mal extremely fast It possible C6S C6Sbinding peptides added PEGMal solution crosslinking act physical barriers crosslinking sites different eightarm PEG molecules leading decreased intermolecular crosslinking weaker gels It possible conjugation C6Sbinding peptides star polymer efficiency crosslinking remaining arms reduced Indeed C6S C6Sbinding peptide incorporated gels PEG gels weakest Further studies needed elucidate crosslinking suppressed 176 Biomatter Volume 1 Issue 2 2011 Landes BioscienceDo distribute Table 2 Summary posthoc test NGF release different gels Gels NGFa 0 peG peGC6S C6S peGBp Bp peGBpC6S BpC6S Bp BpC6S C6S C6S 2 BpC6S Bp BpC6S C6S 4 BpC6S Bp BpC6S C6S BpC6S Time hrsb 7 BpC6S Bp BpC6S C6S BpC6S 18 BpC6S 32 BpC6S 48 BpC6S BpC6S BpC6S BpC6S BpC6S BpC6S BpC6S C6S peG gels gels gels gels gels aGel compositions NGF bAt time point gel statistically significant p 005 gel composition left column listed photobleaching studies dem onstrated C6S gels containing C6Sbinding peptide exhibited lower NGF diffusivity com pared gels C6S only30 immobilized One goals cur rent study investigate effects C6S immobilized gels cortical neuron behavior Previous studies showed DRG neurite extension inhibited chondroitin46sulfate6 der matan sulfate12 agarose gels CS studies modified covalent attachment interfere CScell interactions Therefore PEGpeptide poly saccharide described current study ideal biomate rial investigating effects unmodified CS gels Primary cortical neurons study model cellular behavior following injury central nervous system31 Results showed neurite length number neurites significantly lower gels C6S compared gels C6S demonstrate C6S PEG gels inhibits cortical neurite outgrowth CS influence cell behavior direct inter action indirectly growth factor modulation1932 Thus goal study investigate addition NGF overcome inhibitory effects C6S motivated studies Zhou et al showed NGF promotes DRG growth CSPGcoated slides3335 In current study effects C6S NGF gels cortical neurons investigated In PEG gels NGF average maximum neurite length significantly greater PEG gels NGF This result agrees previous studies demonstrate growthpromoting effects NGF vitro vivo3435 In PEG gels C6S NGF neurite length significantly greater PEG gels C6S NGF However number neurites Figure 4 NGF release profile gels Bp C6S NGF release monitored 48 h After 2 d gels digested NGF quantified peG gels include Bp C6S slowest release peG gels C6S fastest release Mean Se The mechanical strength gels affect NGF release PEG gels In NGF release assay PEG gels C6S C6Sbinding peptide fastest NGF release Since gels weaker PEG gels C6S likely crosslink density decreased increasing molecular weight crosslinks average pore size NGF quickly diffused larger pores characteristic lower crosslink density gels The NGF assay showed PEG gels C6S C6Sbinding peptide released NGF slowest compared gels Although PEGBPC6S gel compliant binding NGF C6S C6Sbinding peptide strong prevent rapid diffusion weaker gel These results C6S C6Sbinding peptide impor tant slow diffusion NGF PEG gels possibly point synergistic NGFbinding activity C6S C6Sbinding peptide NGF release slowest gels contained molecules This hypothesis sup ported work C6S gels fluorescence recovery wwwlandesbiosciencecom Biomatter 177 2011 Landes BioscienceDo distribute Figure 5 effect C6S NGF cortical neuron outgrowth Neurons cultured gels C6S andor NGF 48 h average neurite length A maximum neurite length B number neurites C determined gel composition Mean Se p 005 relative peGBp p 005 relative peGBpC6S p 005 relative peGBpNGF 178 Biomatter Volume 1 Issue 2 2011 Landes BioscienceDo distribute Table 3 peptide summary Peptide Peptide function Peptide sequence Bp C6Sbinding peptide eKRIWFpYRRFGC xlinker bifunctional enzymatically degradable crosslinking peptide GCR GDS GpQ GIA GQG C PEG gels C6S NGF significantly PEG gels C6S NGF Therefore NGF overcome inhibitory effects C6S neurite extension neurite branching outgrowth resulting neurons fewer longer neurites Furthermore shown addition C6Sbinding peptide matrices C6S boosts ability support DRG growth possibly enhanced sequestering NGF inside hydrogel blocking potential C6S inhibition30 In general C6S inhibits neurite outgrowth acts bar rier axon connections development spinal cord injury It hypothesized C6S provides inhibitory substrate growthpromoting molecules growth factors adhere provide guidance cues neurite extension connection32 Therefore PEGpeptide polysac charide incorporates C6S NGF non covalent interactions ideal model developing central nervous One goals neural tissue engineering promote axonal regeneration functional recovery Often use NGF growthpromoting molecules causes uncon trolled increase neurite outgrowth lead super fluous connections cause effects neuropathic pain36 Therefore important neural tissue engineer ing biomaterial encourage neurite outgrowth provide guidance cues meaningful connections37 In study C6S provides inhibitory background NGF promotes neurite outgrowth leading fewer longer neurites Future studies pattern NGF C6S substrates guide neu rite growth functional connections Materials Methods The C6Sbinding peptide identified peptide array screening previous study reference 38 The peptides listed Table 3 synthesized standard Fmoc solid phase chemistry Symphony peptide synthesizer Protein Technologies Inc 200 μM rink amide resin Anaspec 20084 Fmocprotected amino acids activated Obenzotriazol1ylNNNNtetramethyluronium hexa fluorophosphate Synbiosci REAG2 added grow ing peptides 5 M excess After peptide synthesis peptides cleaved resin cleave cocktail containing 925 triflluoroacetic acid Acros Organics 139725000 25 water 25 triisopropylsilane TCI America T1533 25 ethanedithiol Alfa Aesar L12865 Peptides precipitated 10x excess icecold diethyl ether Mallinckrodt Chemicals 084810 centrifuged 5000 rpm 30 min The ether decanted peptide resolubilized water lyophilization Peptide purification performed reverse phase chro matography ÄKTA Explorer GE Healthcare equipped C18 column Grace Vydac 22 mm internal diameter 250 mm length 1015 μm particle size After col umn equilibrated 5 column volumes water contain ing 01 trifluoroacetic acid peptide loaded column subjected increasing linear gradient 0 60 acetonitrile SigmaAldrich 34998 containing 01 tri fluoroacetic acid 12 column volumes The collected peptides lyophilized mass peptide confirmed matrixassisted laser desorptionionizationtime flight mass spectrometry VoyagerDE STR spectrometer Applied Biosystems C6Sbinding peptides conjugated maleimidefunc tionalized eightarm PEGMal MW 40000 gmol Nektar Therapeutics following modified version previous stud ies references 2427 Peptides conjugated PEGMal Michaeltype addition 1x PBS pH 74 Invitrogen 14040182 containing 2 mM EDTA SigmaAldrich E6758 Two arms conjugated C6Sbinding peptide arms crosslinked enzymatically degrad able bifunctional crosslinking peptide First C6Sbinding peptide conjugated PEGMal preparing 2 wv solution PEGMal C6SBP 2molar excess eightarm PEG The solution incubated dark room tempera ture 1 h After conjugation PEGcoC6SBP solution kept dark ice A 2 wv solution C6S SigmaAldrich C4384 added 14 molar ratio C6S PEGcopeptide Finally bifunctional crosslinking peptide xlinker 2 wv solution added 31 molar ratio PEG PEGBP The gels allowed crosslink 1 h room temperature Table 1 shows gel compositions study The viscoelastic properties hydrogels measured Physica MCR 101 rheometer Anton Paar parallelplate geometry 20 mm diameter 100μm gap The temperature rheometer surface controlled 20C builtin Peltier To prevent evaporation sample evaporationblocking chamber lowered sample Gels 100 μl prepared triplicate tested frequency time sweep The linear range viscoelastic response measured frequency sweep 0550 rads 05 strain The time sweep performed angular frequency 10 rads 05 strain 6 min The complex modulus G gel calcu lated averaging G time To determine effects C6Sbinding peptide C6S viscoelastic prop erties material gels tested BP C6S The NGF released gels C6Sbinding peptide C6S quantified Gels 50 μl prepared triplicate 2 ml siliconized tubes previously described contained 2 μgml NGF Invitrogen 13257019 wwwlandesbiosciencecom Biomatter 179 2011 Landes BioscienceDo distribute After gels crosslinked 2 ml 1x PBS added gel At time point 500 μl buffer collected tube immediately replaced 500 μl buffer siliconized pipets tubes NGF release monitored 48 h samples stored 20C After 2 d gels broken spatula digested 10 unitsml collagenase 04 unitsml chondroitinase ABC SigmaAldrich C3667 48 h 37C gentle shaking The NGF collected samples quantified human βNGF ELISA development kit Peprotech 900K60 The absorbance measured 405 nm 650 nm 10 min incu bation ABTS liquid substrate SigmaAldrich A3219 multiwell plate reader FLUOstar Omega BMG Labtech The absorbance 650 nm subtracted absorbance 405 nm determine relative absorbance NGF calculated standard curve To determine biological activity C6S NGF cortical neurons cultured gels C6S NGF Gels 20 μl prepared according previously described protocol39 silicone inserts SigmaAldrich placed cham bered glass slides Nalgene gels chamber Silicone inserts sterilized sonication 90 ethanol VWR Scientific EMEX0276 20 min All materials solutions filtered 02 μm Millipore cell culture Cortex tissue embryonic rat day 18 purchased BrainBits Primary cortical neurons isolated E18 cor tex tissue following protocol BrainBits40 The cortical tissue digested Hibernate E media solution BrainBits HE containing 2 mgml papain Worthington Biochemical Corporation LS003126 37C 30 min The tissue transferred 2 vv solution B27 supplement Invitrogen 17504044 Hibernate media triturated The cell suspension filtered 40μm nylon cell strainer BD Falcon collected The filtered suspension centri fuged 1100 rpm 1 min The supernatant removed cell pellet resuspended 3 ml B27Neurobasal media Invitrogen 21103049 05 mM glutamine Invitrogen 25030149 The viability density cell suspension determined mixing 20 μl Trypan Blue 04 Sigma Aldrich T6146 20 μl cell suspension Cell density counted hemocytometer The cell suspension diluted final concentration 2 x 105 cellsml Supplemented neurobasal media 100 μl added gel 6375 μl cell suspension placed gel The cells incubated 1 h 37C 5 CO2 additional 1 ml media added chamber 2 gels Cells incubated 48 h fixation After 2 d culture cells fixed warm 4 vv paraformaldehyde Electron Microscopy Sciences 19200 1x PBS 1 h room temperature The cells permeabilized 01 Triton X100 SigmaAldrich T8787 solution PBS 2 h After washing 3x PBS 20 min incubations Image iTTM FX signal enhancer Invitrogen I36933 added cells incubated room temperature 2 h The cells washed 3x blocked overnight 1 bovine serum albumin BSA SigmaAldrich A7906 10 goat serum Invitrogen 50062Z After blocking cells washed 6x 01 BSA PBS incubated 5 μgml mouse anti βIIItubulin RD Systems MAB1195 room temperature 2 h overnight 4C The cells washed 3x 01 BSA PBS incubated 2 μgml Alexa488 coupled goat antimouse Fab2fragment secondary antibody Invitrogen A11029 2 h room temperature dark Finally cells washed 3x 01 BSA PBS visualization Images captured Leica DMIRB Leica Microsystems epifluorescence microscope A USH102DH 100W ultrahighpressure mercury lamp USHIO America Inc excitatory light source Images viewed blue excitation range filter set I3excitation filter BP450 490 nm emission filter BP515 nm 20x objective The images analyzed custom Matlab program measured distance neurite center cell body Approximately 100200 neurons analyzed treatment Statistical analysis performed Minitab 15 Minitab SPSS 16 SPSS A oneway ANOVA Tukeys posthoc test α 005 performed determine statistical signifi cance p 005 G different gels time sweep Repeated measures twofactor ANOVA α 005 formed determine statistical significance p 005 G different gels frequency sweep NGF release different gels A Tukeys posthoc test α 005 formed determine significance different gels 10 rads rheology 0 48 h NGF release assay To determine differences cortical neuron outgrowth KruskalWallis MannWhitney posthoc test α 005 performed Conclusions In study effects affinitybased delivery C6S NGF gels cortical neurite behavior investigated C6S NGF incorporated PEG gels C6S binding peptides Gels C6S inhibited neurite outgrowth gels NGF promoted neurite extension The inhibitory activity C6S overcome NGF slowly released PEG gels noncovalent interactions C6S binding peptide C6S NGF The affinitybased devel oped study incorporates C6S NGF ideal biomaterial studying neural development neural tissue engineering Disclosure Potential Conflicts Interest No potential conflicts disclosed Acknowledgments This work funded grant 0017 Arizona Biomedical Research Commission 180 Biomatter Volume 1 Issue 2 2011 Landes BioscienceDo distribute 15 Liu Y Cai SS Shu XZ Shelby J Prestwich GD Release basic fibroblast growth factor cross linked glycosaminoglycan hydrogel promotes wound healing Wound Repair Regen 2007 1524551 PMID17352757 httpdxdoiorg101111j1524 475X200700211x 16 Piai JF Rubira AF Muniz EC Selfassembly swollen chitosanchondroitin sulfate hydrogel ward diffusion chondroitin sulfate chains Acta Biomater 2009 526019 PMID19394902 http dxdoiorg101016jactbio200903035 17 SakiyamaElbert SE Hubbell JA Controlled release nerve growth factor heparincontaining fibrinbased cell ingrowth matrix J Control Release 2000 6914958 PMID11018553 httpdxdoi org101016S0168365900002960 18 SakiyamaElbert SE Hubbell JA Development fibrin derivatives controlled release heparinbind ing growth factors J Control Release 2000 65389 402 PMID10699297 httpdxdoiorg101016 S0168365999002217 19 Raman R Sasisekharan V Sasisekharan R Structural insights biological roles proteinglycosami noglycan interactions Chem Biol 2005 1226777 PMID15797210 httpdxdoiorg101016jchem biol200411020 20 Willerth SM Johnson PJ Maxwell DJ Parsons SR Doukas ME SakiyamaElbert SE Rationally designed peptides controlled release nerve growth fac tor fibrin matrices J Biomed Mater Res A 2007 801323 PMID16958043 httpdxdoi org101002jbma30844 21 Wood MD Borschel GH SakiyamaElbert SE Controlled release glialderived neurotrophic fac tor fibrin matrices containing affinitybased delivery J Biomed Mater Res A 2009 89909 18 PMID18465825 httpdxdoiorg101002 jbma32043 22 Maxwell DJ Hicks BC Parsons S SakiyamaElbert SE Development rationally designed affinitybased drug delivery systems Acta Biomater 2005 1101 13 PMID16701784 httpdxdoiorg101016j actbio200409002 23 Wood MD Moore AM Hunter DA Tuffaha S Borschel GH Mackinnon SE et al Affinitybased release glialderived neurotrophic factor fibrin matrices enhances sciatic nerve regeneration Acta Biomater 2009 595968 PMID19103514 http dxdoiorg101016jactbio200811008 24 Seal BL Panitch A Physical polymer matrices based affinity interactions peptides polysaccharides Biomacromolecules 2003 41572 82 PMID14606882 httpdxdoiorg101021 bm0342032 25 Seal BL Panitch A Physical matrices stabilized enzymatically sensitive covalent crosslinks Acta Biomater 2006 224151 PMID16701884 http dxdoiorg101016jactbio200512008 26 Seal BL Panitch A Viscoelastic behavior envi ronmentally sensitive biomimetic polymer matrices Macromolecules 2006 39226874 httpdxdoi org101021ma0524528 27 Jeong KJ Panitch A Interplay covalent physical interactions environment sensi tive hydrogels Biomacromolecules 2009 101090 9 PMID19301930 httpdxdoiorg101021 bm801270k 28 Conovaloff A Panitch A Characterization chon droitin sulfate hydrogel nerve root regeneration J Neural Eng 2011 8056003 PMID21804177 http dxdoiorg1010881741256085056003 29 Butterfield KC Conovaloff A Caplan M Panitch A Chondroitin sulfatebinding peptides block chon droitin6sulfate inhibition cortical neurite growth Neurosci Lett 2010 478827 PMID20450957 httpdxdoiorg101016jneulet201004070 30 Conovaloff A Beier B Irazoqui P Panitch A Effects synthetic bioactive peptide neurite growth nerve growth factor release chondroitin sulfate hydrogels Biomatter 2011 116573 31 Hains BC Black JA Waxman SG Primary cortical motor neurons undergo apoptosis axotomizing spinal cord injury J Comp Neurol 2003 462328 41 PMID12794736 httpdxdoiorg101002 cne10733 32 Carulli D Laabs T Geller HM Fawcett JW Chondroitin sulfate proteoglycans neural devel opment regeneration Curr Opin Neurobiol 2005 1511620 PMID15721753 httpdxdoi org101016jconb200503018 33 Zhou FQ Walzer M Wu YH Zhou J Dedhar S Snider WD Neurotrophins support regenerative axon assembly CSPGs ECMintegrin independent mechanism J Cell Sci 2006 1192787 96 PMID16772333 httpdxdoiorg101242 jcs03016 34 Bloch J Fine EG Bouche N Zurn AD Aebischer P Nerve growth factor neurotrophin3releasing guidance channels promote regeneration tran sected rat dorsal root Exp Neurol 2001 172425 32 PMID11716566 httpdxdoiorg101006 exnr20017778 35 Colangelo AM Finotti N Ceriani M Alberghina L Martegani E Aloe L et al Recombinant human nerve growth factor marked activity vitro vivo Proc Natl Acad Sci USA 2005 10218658 63 PMID16339317 httpdxdoiorg101073 pnas0508734102 36 Romero MI Rangappa N Garry MG Smith GM Functional regeneration chronically injured sen sory afferents adult spinal cord neuro trophin gene therapy J Neurosci 2001 21840816 PMID11606629 37 Yu LMY Leipzig ND Shoichet MS Promoting neuron adhesion growth Mater Today 2008 113643 httpdxdoiorg101016S1369702108700889 38 Butterfield KC Caplan M Panitch A Identification sequence composition characterization chondroitin sulfatebinding peptides pep tide array screening Biochemistry 2010 491549 55 PMID20095636 httpdxdoiorg101021 bi9021044 39 Eng D Caplan M Preul M Panitch A Hyaluronan scaffolds A balance backbone functionaliza tion bioactivity Acta Biomater 2010 6240714 PMID20051273 httpdxdoiorg101016jact bio200912049 40 Brewer GJ Serumfree B27Neurobasal medium sup ports differentiated growth neurons stria tum substantianigra septum cerebralcortex cerebel lum dentate gyrus J Neurosci Res 1995 42674 83 PMID8600300 httpdxdoiorg101002 jnr490420510 References 1 Sugahara K Mikami T Chondroitindermatan sulfate central nervous Curr Opin Struct Biol 2007 1753645 PMID17928217 httpdxdoi org101016jsbi200708015 2 Kwok JCF Afshari F GarciaAlias G Fawcett J Proteoglycans central nervous Plasticity regeneration stimulation chondroitin ase ABC Restor Neurol Neurosci 2008 2613145 PMID18820407 3 Mizuguchi S Uyama T Kitagawa H Nomura KH Dejima K GengyoAndo K et al Chondroitin proteo glycans involved cell division Caenorhabditis elegans Nature 2003 4234438 PMID12761550 httpdxdoiorg101038nature01635 5 4 Gama CI Tully SE Sotogaku N Clark PM Rawat M Vaidehi N et al Sulfation patterns glycosaminogly cans encode molecular recognition activity Nat Chem Biol 2006 246773 PMID16878128 http dxdoiorg101038nchembio810 Properzi F Carulli D Asher RA Muir E Camargo LM van Kuppevelt TH et al Chondroitin6sulphate synthesis upregulated injured CNS induced injuryrelated cytokines enhanced axongrowth inhibitory glia Eur J Neurosci 2005 2137890 PMID15673437 httpdxdoiorg101111j1460 9568200503876x 6 Gilbert RJ McKeon RJ Darr A Calabro A Hascall VC Bellamkonda RV CS46 differentially upreg ulated glial scar potent inhibitor neurite extension Mol Cell Neurosci 2005 29545 58 PMID15936953 httpdxdoiorg101016j mcn200504006 8 7 Clement AM Sugahara K Faissner A Chondroitin sulfate E promotes neurite outgrowth rat embry onic day 18 hippocampal neurons Neurosci Lett 1999 2691258 PMID10454148 httpdxdoi org101016S0304394099004322 FernaudEspinosa I NietoSampedro M Bovolenta P Differential effects glycosaminoglycans neurite outgrowth hippocampal thalamic neurones J Cell Sci 1994 107143748 PMID7962187 9 Tully SE Mabon R Gama CI Tsai SM Liu X Hsieh Wilson LC A chondroitin sulfate small molecule stimulates neuronal growth J Am Chem Soc 2004 12677367 PMID15212495 httpdxdoi org101021ja0484045 10 Snow DM Brown EM Letourneau PC Growth cone behavior presence soluble chondroitin sulfate proteoglycan CSPG compared behavior CSPG bound laminin fibronectin Int J Dev Neurosci 1996 1433149 PMID8842808 http dxdoiorg1010160736574896000172 11 Dillon GP Yu XJ Bellamkonda RV The polarity magnitude ambient charge influences threedimen sional neurite extension DRGs J Biomed Mater Res 2000 515109 PMID10880096 httpdxdoi org1010021097463620000905513510AID JBM2830CO2G 12 Yu X Bellamkonda RV Dorsal root ganglia neurite extension inhibited mechanical chondroitin sulfaterich interfaces J Neurosci Res 2001 6630310 PMID11592128 httpdxdoiorg101002jnr1225 13 Hwang NS Varghese S Lee HJ Theprungsirikul P Canver A Sharma B et al Response zonal chon drocytes extracellular matrixhydrogels FEBS Lett 2007 58141728 PMID17692846 httpdxdoi org101016jfebslet200707049 14 Varghese S Hwang NS Canver AC Theprungsirikul P Lin DW Elisseeff J Chondroitin sulfate based niches chondrogenic differentiation mesenchymal stem cells Matrix Biol 2008 271221 PMID17689060 httpdxdoiorg101016jmatbio200707002 wwwlandesbiosciencecom Biomatter 181 2011 Landes BioscienceDo distribute